Wednesday, September 12, 2012
Tengion Inc., of Winston-Salem, N.C., said it arranged a one-month bridge loan with leading investors. The loan is expected to facilitate a further $15 million of convertible debt later this month. The company also reported that a sixth patient has been successfully implanted in the ongoing Phase 1 trial of its Neo-Urinary Conduit, for use in bladder cancer patients requiring a urinary diversion following bladder removal.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.